NewsBenzingaSilgan Hldgs Sees Q4 GAAP EPS $0.58-$0.68 vs $0.73 Est Silgan Hldgs Sees Q4 GAAP EPS $0.58-$0.68 vs $0.73 Est Benzinga 2026.10.29 10:02 (GMT+0) Open on Benzinga Other news Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $8 RBC Capital Reiterates Outperform on Shopify, Maintains $200 Price Target Piper Sandler Maintains Underweight on Innovative Ind Props, Raises Price Target to $46 Piper Sandler Maintains Neutral on Atlas Energy Solutions, Lowers Price Target to $13 RBC Capital Maintains Sector Perform on Safehold, Lowers Price Target to $12 Zimmer Biomet Lifts Annual Growth Despite Challenging Knee Market
